Přejít k hlavnímu obsahu
Obrázek záhlaví
User picture
Telefon: +420 585 632 137
Skupiny: DOKTORSKÝ STUDENT, IMTM, LEM, MAGISTERSKÝ STUDENT, PERSONÁL

Doktorské studium

Circulating tumor cells detection

Specializace: Molekulární a translační medicína
Stav: Ongoing od 2020.

Magisterské studium

Circulating tumor cells detection and analysis using direct detection method in patients with glioblastoma multiforme

Stav: Graduated od 2018 do 2020.

O mně

Pavel Stejskal, MSc is involved in the research that aims to understand the additional value of liquid biopsy as a clinically relevant diagnostic, prognostic and predictive tool. His research is focused on the development of experimental models to explain the biology underlying the release of circulating tumor-related materials into blood. He also focuses on the implementation of complex genomic analyses by liquid biopsy-based biomarkers (circulating tumor cells, circulating tumor DNA, extracellular vesicles, free circulating biomarkers) in the diagnosis, follow-up and therapy of cancer patients.

Journals

Minimal residual disease and prognostic significance of circulating tumour cells in early-stage colorectal cancer. Biomedical papers - Olomouc. 2025, ISSN: 1213-8118, PMID: 40832890,  PDF.
MAHESWARAN, S., R. BOREA, D. DE MIGUEL PEREZ, P. PISAPIA, N. GHAZALI, C. MARTINELLI, P. STEJSKAL, C. REDUZZI
Cancer in a Drop: Liquid biopsy insights from AACR 2025. The Journal of Liquid Biopsy. 2025, 8, 100304, ISSN: 2950-1954, PMID: 40613037,  PDF.
Recent Advances in Methods for Circulating Tumor Cell Detection. International Journal of Molecular Sciences. 2023, 24(4), 3902, ISSN: 1422-0067, PMID: 36835311,  PDF.